血清自分泌运动因子与肺部超声评分和ARDS病情及28天死亡的相关性
该研究纳入142例ARDS患者,检测发病当天血清Autotaxin水平及肺部超声评分(LUS),分析其与病情严重程度及28天死亡的关系。结果显示死亡组两项指标均显著高于生存组,重度组高于轻中度组;二者联合预测死亡的AUC为0.904,准确度88.2%;Cox回归显示两项升高均为28天死亡的危险因素。
要点
- 血清Autotaxin水平与LUS评分升高与ARDS病情严重程度相关。
- 两项指标升高均为ARDS患者28天死亡的危险因素。
- 二者联合预测ARDS死亡的AUC为0.904,准确度88.2%。
核心结论
- 血清Autotaxin水平及LUS评分升高与ARDS患者病情较重和死亡有关,是影响28天死亡的危险因素,可作为预测死亡的参考指标。
研究设计与样本
- 选取2019年1月至2021年12月儋州市人民医院收治的142例ARDS患者,检测发病当天血清Autotaxin水平及LUS评分。
- 按入ICU 28天内生存情况分为生存组86例和死亡组56例;按氧合指数分为轻度组36例、中度组61例、重度组45例。
主要发现
- 死亡组血清Autotaxin水平为(54.83±16.28)μg/L,高于生存组的(32.70±11.85)μg/L,t=13.842,P<0.01。
- 死亡组LUS评分为26.50±5.20,高于生存组的13.45±3.70,t=11.974,P<0.01。
- 重度组血清Autotaxin水平及LUS评分均明显高于轻度组和中度组(均P<0.001)。
- 高Autotaxin组生存率44.1%低于低Autotaxin组75.7%(P<0.001);高LUS评分组生存率49.4%低于低LUS评分组73.8%(P=0.003)。
关键数值与推荐
- Autotaxin与LUS评分联合预测ARDS患者死亡的AUC最大为0.904(95%CI:0.847~0.962),准确度最高为88.2%。
- Cox多因素回归显示LUS评分升高为死亡危险因素(HR=1.983,95%CI:1.402~4.715,P<0.001)。
- Cox多因素回归显示Autotaxin水平升高为死亡危险因素(HR=2.604,95%CI:1.853~6.317,P<0.001)。
临床怎么用
- 对ARDS患者可在发病当天检测血清Autotaxin水平并行肺部超声评分,辅助评估病情严重程度与28天死亡风险。
- 两项指标联合应用对预测ARDS患者死亡具有较高价值,可作为参考指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the relationship between serum autocrine motor factor (Autotaxin) level and pulmonary ultrasound score (LUS) and the disease severity and 28-day mortality of patients with acute respiratory distress syndrome (ARDS). Methods: Totally 142 ARDS patients admitted to Danzhou People's Hospital from January 2019 to December 2021 were selected, and serum Autotaxin level and LUS score of ARDS patients on the day of onset were detected. According to the survival within 28 days after entering the intensive care unit, ARDS patients were divided into survival group (86 cases) and death group (56 cases). According to the oxygenation index, ARDS patients were divided into mild group (200 mmHg<oxygenation index≤300 mmHg, 36 cases), moderate group (100 mmHg<oxygenation index≤200 mmHg, 61 cases) and severe group (oxygenation index≤100 mmHg, 45 cases). The receiver operating characteristic curve (ROC) was performed to analyze the value of serum autotaxin level and LUS score to predict the death of patients with ARDS. Kaplan-Meier method was used to draw the survival curve, and Log-rank test was used for comparison between groups. Cox multivariate regression analysis was used to analyze the risk factors of death in patients with ARDS. Results: The LUS score [(26.50±5.20 vs 13.45±3.70, t=11.974,P<0.01] and serum Autotaxin level [(54.83±16.28)μg/L vs (32.70±11.85) μg/L,t=13.842,P<0.01] in the death group were significantly higher than those in the survival group, the difference is statistically significant. The serum autotaxin level and LUS score in severe group were significantly higher than those in mild group and moderate group (all were P<0.001). ROC curve showed that the combino ation of autotaxin and LUS score had the largest AUC to predict the AUC of death in patients with ARDS (0.904, 95CI:0.847-0.962), with the highest accuracy of 88.2%. Survival curve analysis showed that the survival rate of high autotaxin group was significantly lower than that of low autotaxin group (44.1% vs 75.7%,P<0.001), and the survival rate of high LUS score group was significantly lower than that of low LUS score group (49.4% vs 73.8%,P=0.003). Cox multivariate regression analysis showed that elevated LUS score (HR=1.983, 95%CI: 1.402-4.715,P<0.001) and Autotaxin level (HR=2.604, 95%CI: 1.853-6.317,P<0.001) were risk factors for death in patients with ARDS (P<0.05). Conclusion: The increase of serum autotaxin level and LUS score is related to the severity and death of patients with ARDS, which are risk factors for 28-day death in ARDS patients, and can be used as a reference mdicator to predict death in ARDS patients. 目的: 探讨血清自分泌运动因子(Autotaxin)水平及肺部超声评分(LUS)与急性呼吸窘迫综合征(ARDS)患者病情及28 d死亡的关系。 方法: 选取2019年1月至2021年12月儋州市人民医院收治的142例ARDS患者,并检测ARDS患者发病当天血清Autotaxin水平及LUS评分。根据入重症监护室28 d内的生存情况将ARDS患者分为生存组(86例)和死亡组(56例),根据氧合指数将ARDS患者分为轻度组(200 mmHg<氧合指数≤300 mmHg,36例)、中度组(100 mmHg<氧合指数≤200 mmHg,61例)、重度组(氧合指数≤100 mmHg,45例)。绘制受试者工作特征曲线(ROC)分析血清Autotaxin水平及LUS评分预测ARDS患者死亡的价值。采用Kaplan-Meier法绘制生存曲线,组间比较采用Log-rank检验。Cox多因素回归分析影响ARDS患者死亡的危险因素。 结果: 死亡组与生存组血清Autotaxin水平[(54.83±16.28)μg/L vs(32.70±11.85)μg/L,t=13.842,P<0.01]及LUS评分[(26.50±5.20 vs 13.45±3.70,t=11.974,P<0.01],差异有统计学意义。重度组血清Autotaxin水平及LUS评分均明显高于轻度组和中度组(均P<0.001)。Roc曲线显示,Autotaxin及LUS评分二者联合预测ARDS患者死亡的AUC最大(0.904,95%CI:0.847~0.962),其准确度最高为88.2%。生存曲线分析显示,高Autotaxin组生存率明显低于低Autotaxin组(44.1% vs 75.7%,P<0.001),高LUS评分组生存率明显低于低LUS评分组(49.4% vs 73.8%,P=0.003)。Cox 多因素回归分析显示,LUS评分(HR=1.983,95%CI:1.402~4.715,P<0.001)及Autotaxin水平(HR=2.604,95%CI:1.853~6.317,P<0.001)升高为影响ARDS患者死亡的危险因素。 结论: 血清Autotaxin水平及LUS评分升高与ARDS患者病情较重和死亡有关,是影响ARDS患者28 d死亡的危险因素,可作为预测ARDS患者死亡的参考指标。.
引用
- Zheng QM, He YL, Li XD, et al. [Correlation between serum autotaxin level and pulmonary ultrasound score with the disease severity and 28-day mortality in patients with acute respiratory disease syndrome]. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 36617927. doi:10.3760/cma.j.cn112147-20220715-00599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。